METI MEDI Trademark

Trademark Overview


On Monday, November 12, 2018, a trademark application was filed for METI MEDI with the United States Patent and Trademark Office. The USPTO has given the METI MEDI trademark a serial number of 88189799. The federal status of this trademark filing is REGISTERED as of Tuesday, June 16, 2020. This trademark is owned by MetiMedi Pharmaceuticals Co., Ltd.. The METI MEDI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medicines; Crude medicines research; Research on adult diseases; Research on cancer; Pharmaceutical products development; Research on the subject of pharmaceuticals; Pharmaceutical product evaluation; Consultancy pertaining to pharmacology; Research for medical products; Medical research; Chemistry services, namely, chemistry consultation, research in the field of chemistry, laboratory research and analysis in the field of chemistry; Chemical research and analysis; Research and development of medical products for others
meti medi

General Information


Serial Number88189799
Word MarkMETI MEDI
Filing DateMonday, November 12, 2018
Status700 - REGISTERED
Status DateTuesday, June 16, 2020
Registration Number6077568
Registration DateTuesday, June 16, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 31, 2020

Trademark Statements


Description of MarkThe mark consist of the word "METI", wherein the letter "M" is in black and "ETI" are in green, followed by a design of four small circles and one larger circle all of which are orange and above the word "MEDI" in which the letter "M" is in black and "EDI" are in green. The color white in the background is not part of the mark
Pseudo MarkMETI MEDICAL
Pseudo MarkMET I MEDICAL
Indication of Colors claimedThe color(s) black, green and orange is/are claimed as a feature of the mark.
Goods and ServicesResearch and development of vaccines and medicines; Crude medicines research; Research on adult diseases; Research on cancer; Pharmaceutical products development; Research on the subject of pharmaceuticals; Pharmaceutical product evaluation; Consultancy pertaining to pharmacology; Research for medical products; Medical research; Chemistry services, namely, chemistry consultation, research in the field of chemistry, laboratory research and analysis in the field of chemistry; Chemical research and analysis; Research and development of medical products for others

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 29, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMetiMedi Pharmaceuticals Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIncheon 22006
KR

Party NameMetiMedi Pharmaceuticals Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIncheon 22006
KR

Party NameMetiMedi Pharmaceuticals Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIncheon 22006
KR

Trademark Events


Event DateEvent Description
Thursday, March 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 17, 2022TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Thursday, March 17, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, March 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 16, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, March 31, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 31, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 27, 2020CASE RETURNED TO EXAMINATION
Monday, January 27, 2020NOTICE OF ALLOWANCE CANCELLED
Monday, January 27, 2020PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, January 16, 2020TEAS RESPONSE TO PETITION TO DIRECTOR INQUIRY
Friday, January 10, 2020PETITION INQUIRY LETTER MAILED
Monday, January 6, 2020ASSIGNED TO PETITION STAFF
Tuesday, December 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 15, 2019TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, October 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 5, 2019ASSIGNED TO LIE
Tuesday, September 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 12, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 22, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 22, 2019NON-FINAL ACTION E-MAILED
Friday, February 22, 2019NON-FINAL ACTION WRITTEN
Friday, February 15, 2019ASSIGNED TO EXAMINER
Friday, November 30, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, November 29, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 15, 2018NEW APPLICATION ENTERED IN TRAM